These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease. Andoh A, Tsujikawa T, Ban H, Hashimoto T, Bamba S, Ogawa A, Sasaki M, Saito Y, Fujiyama Y. J Gastroenterol Hepatol; 2008 Sep 01; 23(9):1373-7. PubMed ID: 18662197 [Abstract] [Full Text] [Related]
30. [Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease]. Hinojosa J, Molés JR, Nos P, Hoyos M, Ramírez JJ, Primo J, Fernández J, Berenguer J. Rev Esp Enferm Dig; 1995 Nov 01; 87(11):775-80. PubMed ID: 8534531 [Abstract] [Full Text] [Related]
31. [Immunosuppressive treatment of Crohn's disease]. Kasper H, Auer I. Dtsch Z Verdau Stoffwechselkr; 1976 Nov 01; 36(3-4):143-5. PubMed ID: 1021382 [No Abstract] [Full Text] [Related]
35. Treatment of inflammatory bowel disease with azathioprine: how to use it in 1999. Louis E, Belaiche J. Acta Gastroenterol Belg; 1999 Nov 01; 62(4):437-9. PubMed ID: 10692777 [Abstract] [Full Text] [Related]
36. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study. Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM. Hepatogastroenterology; 2006 Nov 01; 53(69):399-404. PubMed ID: 16795981 [Abstract] [Full Text] [Related]
37. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease. Tajiri H, Tomomasa T, Yoden A, Konno M, Sasaki M, Maisawa S, Sumazaki R, Shimizu T, Toyoda S, Etani Y, Nakacho M, Ushijima K, Kobayashi A, Japanese Society for Pediatric Inflammatory Bowel Disease. Digestion; 2008 Nov 01; 77(3-4):150-4. PubMed ID: 18577852 [Abstract] [Full Text] [Related]
38. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease. Glas J, Török HP, Daczo J, Tonenchi L, Folwaczny M, Folwaczny C. Eur J Med Res; 2005 Dec 07; 10(12):535-8. PubMed ID: 16356870 [Abstract] [Full Text] [Related]
39. [When is drug therapy with azathioprine indicated in Crohn's disease?]. Rogler G, Herfarth H. Dtsch Med Wochenschr; 2002 May 31; 127(22):1213-4. PubMed ID: 12035120 [No Abstract] [Full Text] [Related]
40. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. Ananthakrishnan AN, Attila T, Otterson MF, Lipchik RJ, Massey BT, Komorowski RA, Binion DG. J Clin Gastroenterol; 2007 Aug 31; 41(7):682-8. PubMed ID: 17667053 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]